Ghaziabad Online

Systemic Sclerosis Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight

 Breaking News
  • No posts were found

Systemic Sclerosis Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight

May 28
22:11 2021
Systemic Sclerosis Market Analysis, Market Size, Trends, Epidemiology, Leading Companies And Therapies | DelveInsight

DelveInsight Business Research LLP
DelveInsight’s “Systemic Sclerosis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Systemic Sclerosis , historical and forecasted epidemiology as well as the Systemic Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

DelveInsight has launched a new report on “Systemic Sclerosis -Market Insights, Epidemiology, and Market Forecast-2030”.

DelveInsight’sSystemic Sclerosis – Market Insights, Epidemiology, and Market Forecast-2030” report delivers an in-depth understanding of the Systemic Sclerosis, historical and forecasted epidemiology as well as the  Systemic Sclerosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and United Kingdom) and Japan.

Some of the key facts of the Report:

  1. As per the literature review, many geographical variations exist in SSc prevalence, such as a higher number of cases in the USA (276/million) than in Japan and Europe, where a north-south gradient was clearly observed (France: 158/million in 2001 and England: 88/million in 2000).

  2. As per the study, SSc is a rare disease and is diagnosed in approximately 67 male patients and 265 female patients, per 100,000 people each year in the United States.

  3. SSc usually appears in women aged 30–40, and it occurs in slightly older men. In approximately 85% of cases, systemic sclerosis develops in individuals aged 20–60 years.

Key benefits of the report:

1.The Systemic Sclerosis market report covers a descriptive overview and comprehensive insight of the Systemic Sclerosis epidemiology and Systemic Sclerosis market in the 7MM (the United States, EU5 (Germany, Spain, France, Italy, UK) & Japan.)

2.The Systemic Sclerosis market report provides insights on the current and emerging therapies.

3.Systemic Sclerosis market report provides a global historical and forecasted market covering drug outreach in 7MM.

4.The Systemic Sclerosis market report offers an edge that will help in developing business strategies by understanding trends shaping and driving the Systemic Sclerosis market.

Request for sample pages: https://www.delveinsight.com/sample-request/systemic-sclerosis-market

Systemic Sclerosis: Overview

Systemic Sclerosis (SSc) is an autoimmune disease affecting the connective tissue which in turn damages the skin and internal organs. It is characterized by a distinctive pathogenic triad of microvascular damage, deregulation of innate and adaptive immunity, and generalized fibrosis in multiple organs.

The name of the condition comes from the Greek word, ‘sclera’ for hard and ‘derma’ for the skin. This hardening of the skin can be one of the first noticeable symptoms of the condition, due to excessive production of collagen. The excess of collagen can affect the skin, joints, tendons, and internal organs. It causes scarring and stops the affected parts of the body from functioning normally.

The key players involved in the Systemic Sclerosis  market:

  1. Corbus Pharmaceuticals

  2. GenentechGalapagos NV

  3. Kyowa Hakko Kirin

  4. GlaxoSmithKlineKadmon Corporation

  5. Ifetroban

  6. Fibrocell

  7. Forbius

The launch of the emerging therapies is expected to significantly impact the  Systemic Sclerosis treatment scenario in the upcoming years:-

Drug covered

  1. Lenabasum

  2. Pirfenidone

  3. GLPG1690

  4. Brodalumab

  5. GSK2330811

  6. Vasculan

  7. FCX-013

  8. AVID200

Request a free sample report @https://www.delveinsight.com/sample-request/systemic-sclerosis-market

Table of Contents

1. Report Introduction

2. Executive Summary

3. SWOT analysis

4. Systemic Sclerosis Patient Share (%) Overview at a Glance

5. Systemic Sclerosis Market Overview at a Glance

6. Systemic Sclerosis Disease Background and Overview

7. Systemic Sclerosis Epidemiology and Patient Population

8. Country-Specific Patient Population of Systemic Sclerosis 

9. Systemic Sclerosis Current Treatment and Medical Practices

10. Unmet Needs

11. Systemic Sclerosis Emerging Therapies

12. Systemic Sclerosis Market Outlook

13. Country-Wise Systemic Sclerosis Market Analysis (2017–2030)

14. Market Access and Reimbursement of Therapies

15. Market drivers

16. Market barriers

17. Appendix

18. Systemic Sclerosis Report Methodology

19. DelveInsight Capabilities

20. Disclaimer

21. About DelveInsight

Related Reports:

Systemic Sclerosis- Pipeline Insights, 2021

Systemic Sclerosis- Pipeline Insight, 2021” report by DelveInsight outlines comprehensive insights of present clinical development scenarios and growth prospects across the Systemic Sclerosis market. A detailed picture of the Systemic Sclerosis pipeline landscape is provided, which includes the disease overview and Systemic Sclerosis treatment guidelines.

Systemic Sclerosis -Epidemiology Forecast to 2030

DelveInsight’s ‘Systemic Sclerosis- Epidemiology Forecast to 2030’ report delivers an in-depth understanding of the disease, historical and forecasted Systemic Sclerosis{;l epidemiology in the 7MM, i.e., the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and Japan.

Media Contact
Company Name: DelveInsight Business Research LLP
Contact Person: Kritika Rehani
Email: Send Email
Phone: 9193216187
Address:304 S. Jones Blvd #2432
City: Las Vegas
State: Nevada
Country: United States
Website: https://www.delveinsight.com/


Warning: count(): Parameter must be an array or an object that implements Countable in /home/ghaziabadonline/public_html/wp-content/themes/legatus-theme/includes/single/post-tags.php on line 5
Share